We allocate around 18% of our revenue to research and development to provide environmentally sound, safe and efficacious products for the aquaculture industry.
PHARMAQ`s technology ensures high quality research & development enabling us to stay in the forefront with new products and solutions to our global aquaculture customers.
We operate in a dynamic market that requires advanced technical solutions to be developed in shortest possible time.
Our research and development laboratory facilities are fully equipped for contained work on all aspects of vaccine development.
All our fish vaccines are manufactured in a state of the art facility in Overhalla, Norway. Manufacturing of twenty five different fish vaccines involves complex operating procedures as well as logistic challenges. In taking vaccines from the laboratory scale to a commercial production level we believe the long term experience and competencies of our employees add strength to our flexibility and global business.
We also aim to be in forefront within new technologies. As an example we have developed a micro dose vaccine concept that enables the fish farmer to reduce the injection dose to the micro level of 0.05 millilitre per fish. This improves both the side effect profile and growth of the fish. Our customers can benefit from our eagerness to constantly seek new innovative solutions.